Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Continuous Glucose Monitor Dermatitis in Children
Description
Dr. Sarah, a research fellow at the University of Connecticut, presents on the issue of continuous glucose monitor (CGM) dermatitis in children, highlighting two cases of dermatitis resolved after switching devices. CGMs are integral for managing type 1 diabetes, improving quality of life, yet they are associated with significant skin-related issues, affecting up to 67% of child users due to allergens in the devices. Challenges exist in diagnosing CGM dermatitis due to a lack of transparency from manufacturers about device composition and limited patch testing reliability. Common allergens include various acrylates and further complications arise from adhesives and other accessories used along with CGMs. Dr. Sarah emphasizes the importance of thorough patient history, identifying reactions, and the need for better collaboration between pediatricians, dermatologists, and patients. She suggests that allergen test protocols could include broader panels to capture relevant reactions and recommends using a fluticasone spray or physical barriers to mitigate dermatitis risks. Dr. Sarah concludes by calling for enhanced research into device components, increased manufacturer transparency, and better access to alternative CGM models to help manage allergic reactions effectively.
View moreConclusions
- There is a rising prevalence of continuous glucose monitor (CGM) dermatitis in children, especially with increasing CGM usage.
- Changing CGM devices can resolve dermatitis symptoms in some patients.
- Identifying suitable CGMs for patients with a history of dermatitis challenges clinicians due to lack of manufacturer transparency.
- Common allergens associated with CGMs include various acrylates and resins, with underestimation of their prevalence in pediatric cases.
- Patch testing methods for CGM-related dermatitis are limited and complicated by factors such as variable device composition and patient history.
- A team approach involving endocrinologists, dermatologists, and patients is necessary to enhance understanding and solutions to CGM dermatitis.
- Mitigating strategies include using barrier sprays, adjusting wear times, and considering alternative CGM devices.
- Despite ongoing challenges in diagnosis and treatment, future efforts should focus on continued research, increased transparency from manufacturers, and better access to alternative CGM models for patients.
- de Groot A, van Oers EM, Ipenburg NA, Rustemeyer T. Allergic contact dermatitis caused by glucose sensors and insulin pumps: A full review. Contact Dermatitis. 2025;92(2):87-112